Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Sacituzumab Tirumotecan shows promise in treating gynecologic cancers with manageable side effects.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Google should ban ads targeting cancer patients with sensitive health-related keywords to protect them from misleading information.

Accurate gender and sex assessment in dermatology is essential for respectful and precise patient care.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Patients need better counseling and resources for managing chemotherapy-induced hair loss.

FUE hair transplants are generally safe but require careful planning to avoid rare complications.

Post-COVID-19 syndrome is complex, affects 5%-10% of people, and requires better research and global collaboration for treatment.

PCOS, aging, and fertility are linked by hormonal and metabolic issues, with lifestyle changes and treatments offering potential help.

Better supportive care is needed to manage chemotherapy side effects.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Men with hair loss experience lower quality of life, worsened by factors like age, severity, and treatment history.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

Older age, higher BMI, and family history of diabetes increase the risk of gestational diabetes in pregnant women.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

Where melanoma is on the body affects survival chances; melanomas on the back of the head are worse, while those on thighs and arms are less severe, and more sun exposure might improve survival.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

These three weeds have important medicinal properties and need more research for potential pharmaceutical use.

Bleaching hair damages protein structure, especially keratin, leading to weakened hair.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.